Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.

ABSTRACT: The goal of this project was to characterize changes in gene expression in response to the anti-cancer agent sapphyrin PCI-2050. Cultured A549 human lung cancer cells were treated with sapphyrin PCI-2050 or actinomycin D.

ORGANISM(S): Homo sapiens

SUBMITTER: Joseph Gerard Hacia 

PROVIDER: E-GEOD-6400 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress